Impact of prior aspirin use on left ventricular function in ST-elevation myocardial infarction patients undergoing...

Area of Science:

• Cardiology
• Cardiovascular Imaging
• Pharmacology

Background:

• Conflicting evidence exists regarding prior aspirin use and cardiac function in ST-elevation myocardial infarction (STEMI) patients post-primary percutaneous coronary intervention (PPCI).
• Left ventricular (LV) function is a critical determinant of outcomes in STEMI patients.

Purpose of the Study:

• To investigate the impact of prior aspirin use on LV echocardiographic parameters in STEMI patients undergoing PPCI.
• To clarify the relationship between pre-infarction aspirin therapy and cardiac function post-revascularization.

Main Methods:

• A cohort of 260 STEMI patients undergoing PPCI were analyzed.
• Patients were stratified based on prior aspirin use.
• Key echocardiographic parameters including LV ejection fraction (LVEF), left atrial (LA) size, and diastolic function indices were assessed within 72 hours of admission.

Main Results:

• Aspirin users were older, had lower BMI and renal function, and a higher prevalence of hypertension and other cardiovascular medications.
• No significant differences were observed in LVEF, maximal LA size, E/A ratio, or E/e' ratio between aspirin users and non-users.
• The early diastolic velocity (e') was marginally lower in aspirin users (P=0.054), but this did not reach statistical significance after adjusting for confounders.

Conclusions:

• Prior aspirin use does not significantly affect LV echocardiographic parameters in STEMI patients undergoing PPCI.
• These findings remain robust even after accounting for potential confounding variables, suggesting no clinically significant impact on cardiac function.